290 results
Page 3 of 15
8-K
EX-10.2
lwo9zq fgl0
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
8-K
EX-99.2
gwevjdlv6 m47ktyyd
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
424B5
4ngm1z64
11 Dec 20
Prospectus supplement for primary offering
8:02am
424B5
aknzsqqre5cvvr6wu nh
30 Oct 20
Prospectus supplement for primary offering
5:11pm
8-K
EX-10.1
niluu4h
22 Oct 20
Entry into a Material Definitive Agreement
7:12am
8-K
EX-2.1
nn0c5tnl 4aq
11 Sep 20
Lexicon Pharmaceuticals Completes the Sale of Xermelo to
4:11pm
8-K
EX-99.1
zrzbkmutei w4p
30 Jul 20
Lexicon Pharmaceuticals Enters into Agreement
7:18am
8-K
EX-10.1
tn8mpqy62ik8sf kb7
15 Jul 20
Entry into a Material Definitive Agreement
5:06pm
DEFA14A
s5u8wpn3tjluby43q0
13 Mar 20
Additional proxy soliciting materials
7:10am
8-K
EX-10.1
9glsvbassfp3gu se
16 Jan 20
Entry into a Material Definitive Agreement
4:11pm
8-K
6w0l1ptapww5sii7g9d
29 Jul 19
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquistatm (Sotagliflozin) Type 2 Diabetes Phase 3 Program
12:00am